Searched for
DABUR PHARMA
Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...- Stocks in news: SBI, Titan, Hyundai, BSE, Torrent Pharma, Axis BankIndian markets saw volatile trading on Thursday, closing nearly unchanged despite positive signals. Several companies including SBI, Titan,...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 31%If there is no negative development over the next few days, there is unlikely to be pressure on a large part of the market. It is, in fact,...
- El Nino impact: Which stocks will burn & which will fire up as market braces for heat waveIndia faces a strong El Niño, threatening below-normal rainfall and impacting agriculture. While rural-linked sectors like two-wheelers and...
- Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...
- Dabur Pharma gets Government nod for name changeDabur Pharma on Tuesday said it has received the government's approval for changing its name to Fresenius Kabi Oncology.
- German owner taps options on Dabur Pharma delistingGerman company Fresenius Kabi, which recently acquired Dabur Pharma, is learnt to be exploring the possibility of delisting the company fro...
- Dabur Pharma gains on Fresenius investmentShares of Dabur Pharma extended gains after German healthcare group Fresenius said its unit will invest 10-30 million euros over the next 2...
- Open offer to Dabur Pharma shareholders rescheduledDabur Pharma on Tuesday said the open offer to its shareholders by German firm Fresenius Kabi has been rescheduled and will now begin on Ju...
- Fresenius Kabi makes open offer to buy 20% of Dabur PharmaFresenius Kabi, an arm of German healthcare group Fresenius SE, on Wednesday made an open offer to buy an additional 20 per cent in Burman ...
- German co Fresenius Kabi picks up 73% in Dabur PharmaGerman co Fresenius Kabi acquired the stake in Dabur Pharma for around Rs 872 cr. With this, the Burman family exits pharmaceutical biz. Go...
- Dabur Pharma to supply anti-cancer drug to ThailandDabur Pharma has entered into an agreement with Government Pharmaceutical Organization of Thailand for the generic of one of its key anti-c...
- German firm Fresenius leads race for Dabur PharmaSources say that Fresenius Kabi is in advanced talks with the Indian company and has valued Dabur Pharma at over Rs 1,000 cr. Corporate Ind...
- Dabur Pharma gets approval for Irinotecan injectionDabur Pharma has received approval for the launch of Irinotecan hydrochloride injection in US.
- Dabur Pharma weighing PE partner, outright saleThe Dabur Group is learnt to be evaluating a range of options for determining the future direction of Dabur Pharma, the anti-cancer drug co...
- Dabur Pharma forays into Pak anti-cancer drug mktStepping up its overseas expansion, Dabur Pharma has made a foray into the anti-cancer drug market in Pakistan and Turkmenistan.
- Sanofi-Aventis files patent case against Dabur Pharma in USFrench pharma major, Sanofi-Aventis, has filed a lawsuit in the US District Court of New Jersey challenging Dabur Pharma Limited’s Para-1V ...
- US firm files suit against Dabur PharmaUS-based Sanofi-Aventis LLC has filed a lawsuit against Dabur Pharma and its UK arm - Dabur Oncology Pte, over a USFDA filing seeking appro...
- Dabur Pharma sets arm in US to tap oncology mktDabur Pharma on Wednesday said it has set up a subsidiary company in the US, which will be directly responsible for sales, marketing and di...
Load More
